MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.

Ramesh, Shrey; Cifci, Ahmet; Javeri, Saahil; Minne, Rachel; Longhurst, Colin A; Nickel, Kwangok P; Kimple, Randall J; Baschnagel, Andrew M

Ramesh, Shrey; Cifci, Ahmet; Javeri, Saahil; Minne, Rachel; Longhurst, Colin A; Nickel, Kwangok P; Kimple, Randall J; Baschnagel, Andrew M.

Afiliación

Ramesh S; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Cifci A; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Javeri S; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Minne R; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Longhurst CA; Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Nickel KP; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Kimple RJ; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.
Baschnagel AM; University of Wisconsin Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, USA.

bioRxiv ; 2023 10 27.

Article en En | MEDLINE | ID: mdl-37961176

Palabras clave

MET; MET exon 14; capmatinib; non-small cell lung cancer; radiation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google